Cytotoxic T-lymphocyte associated protein 4 inhibitors are associated with a higher risk of cardiovascular events than programmed cell death protein 1 inhibitors in patients with melanoma

Ching Chung Chang, Shao Wei Lo, Hua Ching Chang, Junmin Song, Yu Chang, Kevin Yang, Kuan Yu Chi, Yu Chang, Cho Hung Chiang, Cho Han Chiang

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJournal of the American Academy of Dermatology
DOIs
Publication statusAccepted/In press - 2025

Keywords

  • cardiotoxicity
  • cardiovascular events
  • CTLA-4 inhibitor
  • immune checkpoint inhibitor
  • melanoma
  • PD-1 inhibitor

ASJC Scopus subject areas

  • Dermatology

Cite this